Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

620 ARTÍCULOS , VIENDO DEL 46 AL 60

A Retrospective Study on the Benefits of Combined Citicoline, Memantine, and Acetylcholinesterase Inhibitor Treatments in Older Patients Affected with Alzheimer's Disease

Castagna A, Fabbo A, Manzo C, Lacava R, Ruberto C, Ruotolo G.

J Alzheimers Dis. 2021;79(4):1509-1515. doi: 10.3233/JAD-201211.

Apoptotic neurons and amyloid-beta clearance by phagocytosis in Alzheimer's disease: Pathological mechanisms and therapeutic outlooks

Tajbakhsh A, Read M, Barreto GE, Ávila-Rodriguez M, Gheibi-Hayat SM, Sahebkar A.

Eur J Pharmacol. 2021 Mar 15;895:173873. doi: 10.1016/j.ejphar.2021.173873. Epub 2021 Jan 16.

Exploring the Anti-Neuroinflammatory Potential of Steroid and Terpenoid-Derived Phytochemicals to Combat Alzheimer's Disease

Kabir MT, Uddin MS, Zaman S, Rahman MS, Behl T, Ahmad A, Hafeez A, Perveen A, Ashraf GM.

Curr Pharm Des. 2021;27(22):2635-2647. doi: 10.2174/1381612826666210101152352.

Photoresponsive materials for intensified modulation of Alzheimer's amyloid-β protein aggregation: A review

Liu W, Dong X, Liu Y, Sun Y.

Acta Biomater. 2021 Mar 15;123:93-109. doi: 10.1016/j.actbio.2021.01.018. Epub 2021 Jan 16.

The CITIMERIVA Study: CITIcoline plus MEmantina plus RIVAstigmine in Older Patients Affected with Alzheimer's Disease

Castagna A, Manzo C, Fabbo A, Lacava R, Ruberto C, Ruotolo G.

Clin Drug Investig. 2021 Feb;41(2):177-182. doi: 10.1007/s40261-020-00996-2. Epub 2021 Jan 23.

Amendatory Effect of Flavonoids in Alzheimer's Disease Against Mitochondrial Dysfunction

Gulcan HO, Orhan IE.

Curr Drug Targets. 2021;22(14):1618-1628. doi: 10.2174/1389450122666210120144921.

Astrocyte subtype-specific approach to Alzheimer's disease treatment

Sarkar S, Biswas SC.

Neurochem Int. 2021 May;145:104956. doi: 10.1016/j.neuint.2021.104956. Epub 2021 Jan 24.

Connection between the Altered HDL Antioxidant and Anti-Inflammatory Properties and the Risk to Develop Alzheimer's Disease: A Narrative Review

Zimetti F, Adorni MP, Marsillach J, Marchi C, Trentini A, Valacchi G, Cervellati C.

Oxid Med Cell Longev. 2021 Jan 8;2021:6695796. doi: 10.1155/2021/6695796. eCollection 2021.

The role of post-translational modifications in the regulation of MCL1

Li S, Guo W, Wu H.

Cell Signal. 2021 May;81:109933. doi: 10.1016/j.cellsig.2021.109933. Epub 2021 Jan 27.

Multi-pathogen infections and Alzheimer's disease

Vigasova D, Nemergut M, Liskova B, Damborsky J.

Microb Cell Fact. 2021 Jan 28;20(1):25. doi: 10.1186/s12934-021-01520-7.

APOE: The New Frontier in the Development of a Therapeutic Target towards Precision Medicine in Late-Onset Alzheimer's

Yang A, Kantor B, Chiba-Falek O.

Int J Mol Sci. 2021 Jan 27;22(3):1244. doi: 10.3390/ijms22031244.

TREM2, microglia, and Alzheimer's disease

Qin Q, Teng Z, Liu C, Li Q, Yin Y, Tang Y.

Mech Ageing Dev. 2021 Apr;195:111438. doi: 10.1016/j.mad.2021.111438. Epub 2021 Jan 28.

Interaction of NF-κB and Wnt/β-catenin Signaling Pathways in Alzheimer's Disease and Potential Active Drug Treatments

Liu X, Wang K, Wei X, Xie T, Lv B, Zhou Q, Wang X.

Neurochem Res. 2021 Apr;46(4):711-731. doi: 10.1007/s11064-021-03227-y. Epub 2021 Feb 1.

β-Carboline as a Privileged Scaffold for Multitarget Strategies in Alzheimer's Disease Therapy

Beato A, Gori A, Boucherle B, Peuchmaur M, Haudecoeur R.

J Med Chem. 2021 Feb 11;64(3):1392-1422. doi: 10.1021/acs.jmedchem.0c01887. Epub 2021 Feb 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias